Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $95

Benzinga · 2d ago
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $90 to $95.